Cetirizine Hydrochloride Tablets, 10 mg NDC 25000-220

Product information

Brand name (proprietary)

Cetirizine Hydrochloride Tablets, 10 mg

Generic name (nonproprietary)

cetirizine hydrochloride

Active ingredients

Cetirizine hydrochloride — 10 mg/1

Dosage form

Tablet

Route

Oral

Labeler

MARKSANS PHARMA LIMITED

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 078933

Marketing start

Jan 13, 2022

Listing expires

Dec 31, 2027

Other FDA classes

Histamine H1 Receptor Antagonists (Mechanism)

Identifiers

Product ID 25000-220_172d56b9-ba90-4e1b-934a-f75307564ea3SPL ID 172d56b9-ba90-4e1b-934a-f75307564ea3SPL set ID 652b0c65-a3f2-4454-9cf2-51a3389282ccRxCUI 1014676, 1014678UNII 64O047KTOAUPC 0325000160814, 0325000219147, 0325000219086, 0325000160036, 0325000160142, 0325000220785, 0325000220037, 0325000220082, 0325000219031, 0325000220143, 0325000220815

Pharmacologic class

Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N425000022003 followed by a unit qualifier and the quantity Copy

Package 25000-0220-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 078933

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.